Clinical characteristics of high plasma adiponectin and high plasma leptin as risk factors for arterial stiffness and related end-organ damage

Atherosclerosis

Volumn 235, Issue 2, 2014, Pages 424-429

  Kohara, Katsuhiko ^a   Ochi, Masayuki ^a   Okada, Yoko ^a   Yamashita, Taiji ^a   Ohara, Maya ^a   Kato, Takeaki ^a   Nagai, Tokihisa ^a   Tabara, Yasuharu ^b   Igase, Michiya ^a   Miki, Tetsuro ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adiponectin; End organ damage; Leptin; Skeletal muscle; Visceral fat

Indexed keywords

ADIPONECTIN; ALBUMIN; LEPTIN;

ADULT; AGED; ALBUMINURIA; ARTERIAL STIFFNESS; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; END ORGAN DAMAGE; FEMALE; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; ORGAN INJURY; PRIORITY JOURNAL; PULSE WAVE; SKELETAL MUSCLE; THIGH; URINARY EXCRETION; WHITE MATTER; ANKLE BRACHIAL INDEX; BLOOD; BLOOD FLOW VELOCITY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; RISK FACTOR; SARCOPENIA;

ADIPONECTIN; AGED; ALBUMINURIA; ANKLE BRACHIAL INDEX; BLOOD FLOW VELOCITY; BODY COMPOSITION; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; LEPTIN; MALE; MIDDLE AGED; RISK FACTORS; SARCOPENIA; VASCULAR STIFFNESS;

EID: 84921689330     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.05.940     Document Type: Article

References (37)

1. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7:941-946.
2. Antoniades C., Antonopoulos A.S., Tousoulis D., Stefanadis C. Adiponectin: from obesity to cardiovascular disease. Obes Rev 2009, 10:269-279.
3. Ntaios G., Gatselis N.K., Makaritsis K., Dalekos G.N. Adipokines as mediators of endothelial function and atherosclerosis. Atherosclerosis 2013, 227:216-221.
4. Kanhai D.A., Kranendonk M.E., Uiterwaal C.S., van der Graaf Y., Kappelle L.J., Visseren F.L. Adiponectin and incident coronary heart disease and stroke. A systematic review and meta-analysis of prospective studies. Obes Rev 2013, 14:555-567.
5. Hao G., Li W., Guo R., et al. Serum total adiponectin level and the risk of cardiovascular disease in general population: a meta-analysis of 17 prospective studies. Atherosclerosis 2013, 228:29-35.
6. Gardener H., Goldberg R., Mendez A.J., et al. Adiponectin and risk of vascular events in the Northern Manhattan study. Atherosclerosis 2013, 226:483-489.
7. Persson J., Folkersen L., Ekstrand J., Helleberg J., Gabrielsen A., Lundman P., et al. High plasma adiponectin concentration is associated with all-cause mortality in patients with carotid atherosclerosis. Atherosclerosis 2012, 225:491-496.
8. Beatty A.L., Zhang M.H., Ku I.A., Na B., Schiller N.B., Whooley M.A. Adiponectin is associated with increased mortality and heart failure in patients with stable ischemic heart disease: data from the Heart and Soul Study. Atherosclerosis 2012, 220:587-592.
9. Sweeney G. Cardiovascular effects of leptin. Nat Rev Cardiol 2010, 7:22-29.
10. Devaraj S., Torok N. Leptin: the missing link between obesity and heart disease?. Atherosclerosis 2011, 217:322-323.
11. Beltowski J. Leptin and atherosclerosis. Atherosclerosis 2006, 189:47-60.
12. Chai S.B., Sun F., Nie X.L., Wang J. Leptin and coronary heart disease: a systematic review and meta-analysis. Atherosclerosis 2014, 233:3-10.
13. Kohara K., Ochi M., Tabara Y., Nagai T., Igase M., Miki T. Leptin in sarcopenic visceral obesity: possible link between adipocytes and myocytes. PLoS One 2011, 6(9):e24633.
14. Qasim A., Mehta N.N., Tadesse M.G., Wolfe M.L., Rhodes T., Girman C., et al. Adipokines, insulin resistance, and coronary artery calcification. JAm Coll Cardiol 2008, 52:231-236.
15. Cruz-Jentoft A.J., Landi F., Topinková E., Michel J.P. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 2010, 13:1-7.
16. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., Boirie Y., Cederholm T., Landi F., et al. Sarcopenia: European consensus on definition and diagnosis. Report of the European Working Group on sarcopenia in older people. Age Ageing 2010, 39:412-423.
17. Ochi M., Kohara K., Tabara Y., Kido T., Uetani E., Ochi N., et al. Arterial stiffness is associated with low thigh muscle mass in middle-aged to elderly men. Atherosclerosis 2010, 212:327-332.
18. Sasaki H., Kasagi F., Yamada M., Fujita S. Grip strength predicts cause-specific mortality in middle-aged and elderly persons. Am J Med 2007, 120:337-342.
19. Kohara K., Ochi M., Tabara Y., Nagai T., Igase M., Miki T. Arterial stiffness in sarcopenic visceral obesity in the elderly: J-SHIPP study. Int J Cardiol 2012, 158:146-148.
20. Kamogawa K., Kohara K., Tabara Y., Uetani E., Nagai T., Yamamoto M., et al. Abdominal fat, adipose-derived hormones and mild cognitive impairment: the J-SHIPP study. Dement Geriatr Cogn Disord 2010, 30:432-439.
21. Ochi N., Tabara Y., Igase M., Nagai T., Kido T., Miki T., et al. Silent cerebral microbleeds associated with arterial stiffness in an apparently healthy subject. Hypertens Res 2009, 32:255-260.
22. Anew guideline making committee of a brain dock. Braindock Guideline 2003, 25-28. Japanese Society for Detection of Asymptomatic Brain Disease, 39-44.
23. Matsumoto M., Ishikawa S., Kajii E. Association of adiponectin with cerebrovascular disease: a nested case-control study. Stroke 2008, 39:323-328.
24. Rana J.S., Arsenault B.J., Després J.P., CÔté M., Talmud P.J., Ninio E., et al. Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women. Eur Heart J 2011, 32:336-344.
25. Frystyk J., Berne C., Berglund L., Jensevik K., Flyvbjerg A., Zethelius B. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. JClin Endocrinol Metab 2007, 92:571-576.
26. Pischon T., Hu F.B., Girman C.J., Rifai N., Manson J.E., Rexrode K.M., et al. Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women. Atherosclerosis 2011, 219:322-329.
27. Prado C.M., Wells J.C., Smith S.R., Stephan B.C., Siervo M. Sarcopenic obesity: a critical appraisal of the current evidence. Clin Nutr 2012, 31:583-601.
28. Kohara K. Sarcopenic obesity in aging population: current status and future directions for research. Endocrine 2014, 45:15-25.
29. Auyeung T.W., Lee J.S., Leung J., Kwok T., Woo J. Adiposity to muscle ratio predicts incident physical limitation in a cohort of 3,153 older adults-an alternative measurement of sarcopenia and sarcopenic obesity. Age 2013, 35:1377-1385.
30. Ochi M., Tabara Y., Kido T., Uetani E., Ochi N., Igase M., et al. Quadriceps sarcopenia and visceral obesity are risk factors for postural instability in the middle-aged to elderly population. Geriatr Gerontol Int 2010, 10:233-243.
31. Beijers H.J., Ferreira I., Bravenboer B., Henry R.M., Schalkwijk C.G., Dekker J.M., et al. Higher central fat mass and lower peripheral lean mass are independent determinants of endothelial dysfunction in the elderly: the Hoorn study. Atherosclerosis 2014, 233:310-318.
32. Wong T.Y., Klein R., Sharrett A.R., Couper D.J., Klein B.E., Liao D.P., et al. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002, 288:67-74.
33. Vermeer S.E., Hollander M., van Dijk E.J., Hofman A., Koudstaal P.J., Breteler M.M. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003, 34:1126-1129. Rotterdam Scan Study.
34. Solbu M.D., Kronborg J., Jenssen T.G., Njølstad I., Løchen M.L., Mathiesen E.B., et al. Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events. Atherosclerosis 2009, 204:503-508.
35. Matsushita K., van der Velde M., Astor B.C., Woodward M., Levey A.S., de Jong P.E., et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010, 375:2073-2081. Chronic Kidney Disease Prognosis Consortium.
36. Ohara M., Kohara K., Tabara Y., Ochi M., Nagai T., Igase M., et al. Sarcopenic obesity and arterial stiffness, pressure reflection and central pulse pressure: the J-SHIPP study. Int J Cardiol 2014, 174:214-217.
37. Kohara K. Central blood pressure and end-organ damage. Curr Hypertens Rev 2012, 8:100-107.